logo-loader
viewCanafarma

Canafarma Hemp partners with Dutch pharma company to develop hemp-based time released capsule

CanaFarma Hemp Products Corp. (CSE:CNFA) COO Frank Barone tells Proactive the group has partnered with Dutch pharmaceutical company APeT BV to develop hemp-based cannabinoid, drug and nutritional supplement delivery methods using its FLOTEX‐C patented technology. Barone says FLOTEX‐C ensures active ingredients are delivered in a time released manner via a capsule that "floats" within the stomach, taking about 24 hours to dissolve, allowing the user to receive the proper dosage.

Quick facts: Canafarma

Price: 0.46 CAD

CSE:CNFA
Market: CSE
Market Cap: $86.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canafarma named herein, including the promotion by the Company of Canafarma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Canafarma's DTC marketing strategy 'an important driver' for the company -...

Proactive Research analyst Ed Stacey says CanaFarma Hemp Products Corp (CSE:CNFA, FRA:4K9) has a vertically integrated ‘farm-to-table’ strategy encompassing cultivation, extraction/process, manufacture of branded consumer products and sales & marketing. Stacey says the firm is...

on 7/5/20

2 min read